Ypsomed system and Dexcom's CGM

Ypsomed partners with Dexcom

Ypsomed Diabetescare Stories

We have recently entered a partnership with Dexcom to improve your diabetes therapy system. This partnership will make it possible for you to use the Dexcom G6 CGM system as part of the Ypsomed Diabetescare therapy system. Thanks to this integration, you will be able to review YpsoPump insulin data as well as Dexcom’s continuous glucose monitoring data in your Ypsomed App on your smartphone.

Montréal, Canada - The Ministry of Health of the Canadian Ontario region has added the YpsoPump insulin pump to its list of approved devices funded by the Assistive Device Program (ADP). As of 13 January 2020, the YpsoPump is officially reimbursed in the Ontario region and can be prescribed by health care professionals to people with diabetes that qualify for insulin pump therapy under the ADP.